Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ERC Biotechnology (ERCBIO) is a Turkish biotechnology company specializing in the development and manufacturing of innovative bioimplant gels and medical devices. Founded in 2016 and headquartered at Istanbul Sağlık Bilimleri University-Teknopol Istanbul, the company focuses on therapeutic areas such as orthopedics, dermatology, and tissue regeneration. ERCBIO operates as both a product developer and a contract development and manufacturing organization (CDMO), offering services in R&D, cleanroom filling, and laboratory solutions under GMP and ISO standards. Their core product line includes advanced hydrogel-based solutions designed for joint health and aesthetic applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ERC Nano Med.